Literature DB >> 12533690

Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas.

Levent Bekir Beder1, Mehmet Gunduz, Mamoru Ouchida, Kunihiro Fukushima, Esra Gunduz, Sachio Ito, Akiko Sakai, Noriyuki Nagai, Kazunori Nishizaki, Kenji Shimizu.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a frequent malignancy with a poor survival rate. Identifying the tumor suppressor gene (TSG) loci by genomic studies is an important step to uncover the molecular mechanisms involved in HNSCC pathogenesis. We therefore performed comprehensive analyses on loss of heterozygosity (LOH) using a genome-wide panel of 191 microsatellite markers in 22 HNSCC samples. We found 53 markers with significantly high LOH (>30%) on 21 chromosomal arms; the highest values of those were observed on 3p, 9p, 13q, 15q, and 17p, corresponding to D3S2432 (67%), D9S921-D9S925 (67%) and GATA62F03 (86%), D13S1493 (60%), D15S211 (62%), and D17S1353 (88%), respectively. Fifteen hot spots of LOH were defined in 13 chromosomal arms: 2q22-23, 4p15.2, 4q24-25, 5q31, 8p23, 9p23-24, 9q31.3, 9q34.2, 10q21, 11q21-22.3, 14q11-13, 14q22.3, 17p13, 18q11, and 19q12 as loci reported previously in HNSCCs. Furthermore, we identified five novel hot spots of LOH on three chromosomal arms in HNSCC at 2q33 (D2S1384), 2q37 (D2S125), 8q12-13 (D8S1136), 8q24 (D8S1128), and 15q21 (D15S211). In conclusion, our comprehensive allelotype analyses have unveiled and confirmed a total of 20 possible TSG loci that could be involved in the development of HNSCC. These results provide useful clues for identification of putative TSGs involved in HNSCC by fine mapping of the suspected regions and subsequent analysis for functional genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12533690     DOI: 10.1097/01.lab.0000047489.26246.e1

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  22 in total

1.  Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma.

Authors:  Gurkan Bebek; Mohammed Orloff; Charis Eng
Journal:  J Clin Bioinforma       Date:  2011-08-02

2.  Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.

Authors:  Su Man Lee; Jae Yong Park; Dong Sun Kim
Journal:  Mol Cells       Date:  2012-07-18       Impact factor: 5.034

3.  RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity.

Authors:  Masashi Mukohda; Shi Fang; Jing Wu; Larry N Agbor; Anand R Nair; Stella-Rita C Ibeawuchi; Chunyan Hu; Xuebo Liu; Ko-Ting Lu; Deng-Fu Guo; Deborah R Davis; Henry L Keen; Frederick W Quelle; Curt D Sigmund
Journal:  J Clin Invest       Date:  2019-03-21       Impact factor: 14.808

Review 4.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

5.  Amplification and deletion of the RAPH1 gene in breast cancer patients.

Authors:  Meire S Batistela; Dellyana R Boberg; Fabiana A Andrade; Michelli Pecharki; Enilze M de S F Ribeiro; Iglenir J Cavalli; Rubens S Lima; Cícero A Urban; Lupe Furtado-Alle; Ricardo L R Souza
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

6.  Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas.

Authors:  Brandon Griess; David Klinkebiel; Alice Kueh; Michelle Desler; Kenneth Cowan; Matthew Fitzgerald; Melissa Teoh-Fitzgerald
Journal:  Epigenetics       Date:  2020-06-14       Impact factor: 4.528

7.  Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.

Authors:  Levent B Beder; Mehmet Gunduz; Mamoru Ouchida; Esra Gunduz; Akiko Sakai; Kunihiro Fukushima; Hitoshi Nagatsuka; Sachio Ito; Noriyasu Honjo; Kazunori Nishizaki; Kenji Shimizu
Journal:  J Cancer Res Clin Oncol       Date:  2005-09-17       Impact factor: 4.553

Review 8.  [HPV-associated head and neck cancer. The basics of molecular and translational research].

Authors:  C Wittekindt; S Wagner; J P Klussmann
Journal:  HNO       Date:  2011-09       Impact factor: 1.284

9.  Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.

Authors:  Baoping Cao; Yunsheng Yang; Yuanming Pan; Yan Jia; Malcolm V Brock; James G Herman; Mingzhou Guo
Journal:  Discov Med       Date:  2013-10       Impact factor: 2.970

10.  Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population.

Authors:  S Mitra; S Banerjee; C Misra; R K Singh; A Roy; A Sengupta; C K Panda; S Roychoudhury
Journal:  J Clin Pathol       Date:  2006-11-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.